Regeneron Pharmaceuticals, Inc.

NasdaqGS:REGN Stock Report

Market Cap: US$111.8b

Regeneron Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:REGN Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
26 Feb 24SellUS$990,000Joseph LaRosaIndividual1,000US$990.00
22 Feb 24SellUS$967,650Joseph LaRosaIndividual1,000US$967.65
14 Feb 24SellUS$9,831,727Daniel Van PlewIndividual10,434US$951.77
09 Feb 24SellUS$4,689,320Christopher FenimoreIndividual4,919US$955.00
07 Feb 24SellUS$7,637,954Neil StahlIndividual8,037US$953.00
07 Feb 24SellUS$950,000Joseph LaRosaIndividual1,000US$950.00
05 Feb 24SellUS$934,710Marion McCourtIndividual1,000US$934.71
23 Aug 23SellUS$188,212Robert LandryIndividual223US$844.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of REGN?
Owner TypeNumber of SharesOwnership Percentage
Private Companies9,7800.00907%
State or Government121,4000.113%
Individual Insiders4,347,2294.03%
General Public8,646,1518.01%
Institutions94,760,94387.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 65.26% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.69%
FMR LLC
10,455,326US$10.8b4.59%0.67%
8.28%
The Vanguard Group, Inc.
8,930,241US$9.3b1.04%0.15%
7.94%
BlackRock, Inc.
8,568,654US$8.9b-0.71%0.15%
7.8%
Capital Research and Management Company
8,417,875US$8.7b-2.89%0.43%
6.28%
JP Morgan Asset Management
6,771,382US$7.0b6.38%0.84%
4.49%
State Street Global Advisors, Inc.
4,841,548US$5.0b-1.22%0.2%
2.24%
Leonard Schleifer
2,421,124US$2.5b-0.03%no data
2.2%
Geode Capital Management, LLC
2,376,591US$2.5b0.95%0.19%
2.19%
Dodge & Cox
2,359,864US$2.4b-0.33%0.74%
1.14%
Putnam LLC
1,233,226US$1.3b1.86%1.35%
1.12%
Loomis Sayles & Company, L.P.
1,207,195US$1.3b-0.97%1.7%
1.07%
George Yancopoulos
1,153,695US$1.2b-11.9%no data
1.01%
Wellington Management Group LLP
1,092,975US$1.1b-0.83%0.17%
0.99%
Amundi Asset Management SAS
1,065,132US$1.1b15.9%0.23%
0.98%
Norges Bank Investment Management
1,061,803US$1.1b0%0.09%
0.92%
Northern Trust Global Investments
991,465US$1.0b-5.25%0.16%
0.91%
Legal & General Investment Management Limited
977,941US$1.0b-0.77%0.2%
0.87%
UBS Asset Management AG
942,045US$976.4m17.6%0.12%
0.84%
T. Rowe Price Group, Inc.
902,613US$935.6m25.7%0.08%
0.82%
American Century Investment Management Inc
881,905US$914.1m-5.31%0.48%
0.81%
BNY Asset Management
878,756US$910.9m-6.64%0.17%
0.75%
Morgan Stanley, Investment Banking and Brokerage Investments
810,554US$840.2m28.7%0.11%
0.68%
AllianceBernstein L.P.
736,533US$763.4m-1.03%0.23%
0.64%
JPMorgan Chase & Co, Private Banking and Investment Banking Investments
694,318US$719.7m7.03%0.2%
0.59%
Charles Schwab Investment Management, Inc.
638,223US$661.5m2.84%0.11%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.